Wells AD - Search Results

1

Signals from CD28 induce stable epigenetic modification of the IL-2 promoter.

Thomas RM, Gao L, Wells AD. Thomas RM, et al. Among authors: wells ad. J Immunol. 2005 Apr 15;174(8):4639-46. doi: 10.4049/jimmunol.174.8.4639. J Immunol. 2005. PMID: 15814687

2

Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity.

Gudmundsdottir H, Wells AD, Turka LA. Gudmundsdottir H, et al. Among authors: wells ad. J Immunol. 1999 May 1;162(9):5212-23. J Immunol. 1999. PMID: 10227995

3

Enhanced surface TCR replenishment mediated by CD28 leads to greater TCR engagement during primary stimulation.

Schrum AG, Wells AD, Turka LA. Schrum AG, et al. Among authors: wells ad. Int Immunol. 2000 Jun;12(6):833-42. doi: 10.1093/intimm/12.6.833. Int Immunol. 2000. PMID: 10837411

4

T cell effector function and anergy avoidance are quantitatively linked to cell division.

Wells AD, Walsh MC, Sankaran D, Turka LA. Wells AD, et al. J Immunol. 2000 Sep 1;165(5):2432-43. doi: 10.4049/jimmunol.165.5.2432. J Immunol. 2000. PMID: 10946268

5

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Suchin EJ, et al. Among authors: wells ad. J Immunol. 2001 Jan 15;166(2):973-81. doi: 10.4049/jimmunol.166.2.973. J Immunol. 2001. PMID: 11145675

6

Regulation of T cell activation and tolerance by phospholipase C gamma-1-dependent integrin avidity modulation.

Wells AD, Liu QH, Hondowicz B, Zhang J, Turka LA, Freedman BD. Wells AD, et al. J Immunol. 2003 Apr 15;170(8):4127-33. doi: 10.4049/jimmunol.170.8.4127. J Immunol. 2003. PMID: 12682243

7

Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: implications for peripheral B and T cell responsiveness.

Chung JB, Wells AD, Adler S, Jacob A, Turka LA, Monroe JG. Chung JB, et al. Among authors: wells ad. J Immunol. 2003 Aug 15;171(4):1758-67. doi: 10.4049/jimmunol.171.4.1758. J Immunol. 2003. PMID: 12902475

8

Notch signaling augments T cell responsiveness by enhancing CD25 expression.

Adler SH, Chiffoleau E, Xu L, Dalton NM, Burg JM, Wells AD, Wolfe MS, Turka LA, Pear WS. Adler SH, et al. Among authors: wells ad. J Immunol. 2003 Sep 15;171(6):2896-903. doi: 10.4049/jimmunol.171.6.2896. J Immunol. 2003. PMID: 12960312

9

Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.

Lee I, Wang L, Wells AD, Ye Q, Han R, Dorf ME, Kuziel WA, Rollins BJ, Chen L, Hancock WW. Lee I, et al. Among authors: wells ad. J Immunol. 2003 Dec 15;171(12):6929-35. doi: 10.4049/jimmunol.171.12.6929. J Immunol. 2003. PMID: 14662900

10

B7-H3 promotes acute and chronic allograft rejection.

Wang L, Fraser CC, Kikly K, Wells AD, Han R, Coyle AJ, Chen L, Hancock WW. Wang L, et al. Among authors: wells ad. Eur J Immunol. 2005 Feb;35(2):428-38. doi: 10.1002/eji.200425518. Eur J Immunol. 2005. PMID: 15682454 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters